MYASTHAENIA GRAVIS
Clinical trials for MYASTHAENIA GRAVIS explained in plain language.
Never miss a new study
Get alerted when new MYASTHAENIA GRAVIS trials appear
Sign up with your email to follow new studies for MYASTHAENIA GRAVIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a One-Time cell therapy ease myasthenia gravis? new trial launches
Disease control Recruiting nowThis phase 3 study tests an experimental treatment called Descartes-08 for adults with generalized myasthenia gravis, a condition causing muscle weakness. The therapy uses modified immune cells (mRNA CAR T-cells) to target the disease. About 100 participants will receive either t…
Matched conditions: MYASTHAENIA GRAVIS
Phase: PHASE3 • Sponsor: Cartesian Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
CAR T-Cell therapy: what happens years later?
Knowledge-focused Recruiting nowThis study follows about 70 people who have already received KYV-101, a CAR T-cell therapy, for autoimmune diseases like lupus and multiple sclerosis. Researchers will monitor participants for up to 15 years to track any delayed side effects, new cancers, or other health problems…
Matched conditions: MYASTHAENIA GRAVIS
Sponsor: Kyverna Therapeutics • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:05 UTC